A ferritin-targeted biohybrid triggering ferroptosis immunotherapy via activating endogenous iron and replenishing exogenous iron simultaneously

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-61419-4
Affiliations:
3
Authors:
8
Go to article
Institutions Authors Share
State Key Laboratory of Advanced Medical Materials and Devices, China
7.333333
 0.92
Furong Laboratory, China
0.333333
 0.04
Central South University (CSU), China
0.333333
 0.04
Interested in Oncology and Carcinogenesis?